Post date December 6, 2023 Experience Veoneer sale of Restraint Control Systems business to AIP We are advising Veoneer and SSW Partners on the sale
Post date November 30, 2023 Experience Cadre acquisition by Yieldstreet We are advising Cadre on the transaction
Post date November 14, 2023 Experience Bristol Myers Squibb $4.5 billion notes offering The investment-grade offering comprised four tranches
Post date November 10, 2023 Experience Atlanta Braves $60.9 million debt-for-equity exchange and secondary offering We advised the debt exchange party and the secondary offering underwriter
Post date November 6, 2023 Experience Williams acquisitions of Cureton and Rocky Mountain Midstream We are advising Williams on the acquisitions
Post date October 31, 2023 Experience GSK exclusive license agreement for HS-20089 with Hansoh Pharma We advised GSK on the transaction
Post date September 12, 2023 Experience Marsh McLennan $1.6 billion senior notes offering We advised Marsh McLennan on its investment-grade notes offering
Post date September 7, 2023 Experience Summit Materials $3.2 billion combination with Argos USA We are advising Summit Materials on the transaction
Post date August 23, 2023 Experience Johnson & Johnson splits off Kenvue This is the largest split-off transaction ever done
Post date August 7, 2023 Experience Virgin Orbit chapter 11 plan confirmed We advised Virgin Investments as DIP lender, prepetition lender and equityholder in connection with the restructuring